Xigduo XR approved in China for adults with type-2 diabetes – AstraZeneca06/27/2023 majac Diabetes the global diabetes program for Xigduo XR, which provided clinical evidence for the efficacy and safety profile of dapagliflozin and metformin …Share on FacebookTweetFollow usSave